【レポートの概要（一部）】
1. Introduction to Cancer Immunotherapy
2. Classification of Cancer Immunotherapy
2.1 Specific Cancer Immunotherapy
2.2 Non-Specific Cancer Immunotherapy
3. Cancer Immunotherapy by Vaccines
3.1 Introduction
3.2 Mechanism of Vaccines in Cancer Immunotherapy
3.2.1 Idiotype Cancer Vaccine Mechanism
3.2.2 Cellular Cancer Vaccines Mechanism
3.2.3 Ganglioside Antigens based Cancer Vaccines Mechanism
3.2.4 Peptide Cancer Vaccine Mechanism
3.2.5 Tumor Host Interaction Cancer Vaccine Mechanism
4. Cancer Immunotherapy by Monoclonal Antibodies
4.1 Introduction
4.2 Mechanism of Monoclonal Antibodies in Cancer Immunotherapy
5. Cancer Immunotherapy by Adoptive Cell Transfer
5.1 Introduction
5.2 Mechanism of Adoptive Cell Transfer Cancer Immunotherapy
6. Cancer Immunotherapy by Immune Checkpoint Inhibitors
6.1 Introduction
6.2 Mechanism of Immune Checkpoint Inhibitors in Cancer Immunotherapy
7. Cancer Immunotherapy by Immunomodulators
7.1 Introduction
7.2 Mechanism of Immunomodulators in Cancer Immunotherapy
8. Cancer Immunotherapy by Cytokines
8.1 Introduction
8.2 Mechanism of Cytokines Cancer Immunotherapy
9. Cancer Immunotherapy by Interleukins
9.1 Introduction
9.2 Mechanism of Interleukinsin Cancer Immunotherapy
10. Cancer Immunotherapy by Interferon
10.1 Introduction
10.2 Mechanism of Interferon Cancer Immunotherapy
11. Cancer Immunotherapy by GM-CSF
11.1 Introduction
11.2 Mechanism of GM-CSF Cancer Immunotherapy
12. Cancer Immunotherapy Market Overview
12.1 Current Market Scenario
12.2 Cancer Immunotherapy Pipeline Overview
13. Global Cancer Immunotherapy Market Dynamics
13.1 Favorable Market Parameters
13.2 Commercialization Challenges
14. Global Cancer Immunotherapy Market Future Prospects
15. Cancer Cell Therapies Clinical Pipeline by Company, Indication & Phase
15.1 Unknown
15.2 Research
15.3 Preclinical
15.4 Clinical
15.5 Phase-I
15.6 Phase-I/II
15.7 Phase-II
15.8 Phase-III
15.9 Preregistration
16. Marketed Cancer Cell Therapies Drugs Clinical Insight
16.1 Sipuleucel-T (Provenge®)
16.2 T-Lymphocyte Cell Therapy(Immuncell-LC®)
17. Cancer Cytokines Clinical Pipeline by Company, Indication & Phase
17.1 Unknown
17.2 Research
17.3 Preclinical
17.4 Clinical
17.5 Phase-I
17.6 Phase-I/II
17.7 Phase-II
17.8 Phase-III
18. Marketed Cancer Cytokines Drugs Clinical Insight
18.1 Aldesleukin (Proleukin®)
18.2 Denileukin Diftitox (ONTAK®)
18.3 Interferon Alpha (Multiferon®)
18.4 Interferon Alpha-2a (Roferon-A®)
18.5 Interferon Alpha-2a (Veldona®)
18.6 Interferon Alpha-2a Biosimilar(Inferon™/Inmutag™)
18.7 Interferon Alpha-2b(Intron® A)
18.8 Interferon Alpha-2b Biosimilar(Bioferon™)
18.9 Interferon Alpha-2b Biosimilar (Intalfa®)
18.10 Interferon Alpha-2b Biosimilar
18.11 Interferon-Alpha-n3 (Alferon N®)
18.12 Interferon-Beta-1b (Feron®)
18.13 Interferon-Gamma (Ogamma®)
18.14 Interleukin-2 Biosimilar (Ilcass)
18.15 Teceleukin (Imunace™)
19. Cancer Immunomodulators Clinical Pipeline By Company, Indication & Phase
19.1 Unknown
19.2 Research
19.3 Preclinical
19.4 Clinical
19.5 Phase-I
19.6 Phase-I/II
19.7 Phase-II
19.8 Phase-II/III
19.9 Phase-III
19.10 Preregistration
19.11 Registered
20. Marketed Cancer Immunomodulators Clinical Insight
21. Cancer Vaccine Clinical Pipeline By Company, Indication & Phase
21.1 Research
21.2 Preclinical
21.3 Clinical
21.4 Phase-I
21.5 Phase-I/II
21.6 Phase-II
21.7 Phase-II/III
21.8 Phase-III
21.9 Preregistration
21.10 Registered
22. Marketed Cancer Vaccines Clinical Insight
22.1 Bladder Cancer Vaccine (PACIS®)
22.2 Bladder Cancer Vaccine
22.3 BV NSCLC 001
22.4 Dendritic Cell Vaccine (CreaVax-HCC®, CreaVax-PC® & CreaVax-RCC®)
22.5 Human Papillomavirus Vaccine Quadrivalent (Gardasil®/Silgard®)
22.6 Human Papillomavirus Vaccine Recombinant Bivalent (Cervarix®)
22.7 Melanoma Vaccine (MVax®)
22.8 Melanoma Vaccine (Melacine®)
22.9 Racotumomab (Vaxira®)
22.10 Sipuleucel-T (Provenge®)
22.11 Tertomotide (LucaVax)
22.12 Vitespen (Oncophage®)
23. Cancer Monoclonal Antibodies Clinical Pipeline by Company, Indication & Phase
23.1 Unknown
23.2 Research
23.3 Preclinical
23.4 Clinical
23.5 Phase-I
23.6 Phase-I/II
23.7 Phase-II
23.8 Phase-II/III
23.9 Phase-III
23.10 Preregistration
23.11 Registered
24. Marketed Cancer Monoclonal Antibodies Drugs Clinical Insight
25. Competitive Landscape
25.1 Abbvie
25.2 Advaxis
25.3 Altor BioScience
25.4 Amgen
25.5 Biogen Idec
25.6 Biogenomics
25.7 Celldex Therapeutics
25.8 Dendreon Corporation
25.9 Eli Lilly
25.10 Expression Genetics
25.11 Galena Biopharma
25.12 Genmab
25.13 Gilead Sciences
25.14 GlaxoSmithKline
25.15 ImmunoCellular Therapeutics
25.16 ImmunoGen
25.17 Inovio Pharmaceuticals
25.18 IRX Therapeutics
25.19 Merck
25.20 NeoStem Oncology
25.21 NewLink Genetics
25.22 Northwest Biotherapeutics
25.23 Novartis
25.24 Peregrine Pharmaceuticals
25.25 Pfizer
25.26 Philogen
25.27 Regulon
25.28 Roche
25.29 Seattle Genetics
25.30 ZymoGenetics
【レポート販売概要】
■ タイトル：癌免疫療法の世界市場動向■ 英文：Global Cancer Immunotherapy Market Outlook 2020
■ 発行日：2015年6月
■ 調査会社：KuicK Research
■ 商品コード：KUIK506192
■ 調査対象地域：グローバル
- スロットマシンの世界市場2017-2021About Slot MachinesSlot machines are casino gambling machines with three or more reels that spin when a button is pushed. Technavio’s analysts forecast the global slot machines market to grow at a CAGR of 15.49% during the period 2017-2021. [Covered in this report] The report covers the present scenario and the growth prospects of the global slot machines market for 2017-2021. To calculate the mar …
- グルコース/デキストロース/マルトデキストリンの世界市場予測（～2021）The global glucose, dextrose, and maltodextrin market has grown exponentially in the last few years. The market size is projected to reach USD 42.20 Billion by 2021, at a CAGR of around 6.7% from 2016 to 2021. Emerging countries such as India and China are the primary targets of this industry. Increasing demand for convenience food & beverages, research & development activities, and the increasing …
- セキュリティインテリジェンスおよび分析ソリューションの世界市場2016-2020About the Security Intelligence and Analytics Solutions Market Security intelligence helps preventing attacks such as advanced persistent threat and advanced malware. These emerging cyber-attacks are immune to the traditional security methods. Organizations need a proactive intelligent system to prevent these attacks, as they can lead to misuse or tampering of data. Security intelligence service i …
- Contact Exploration Inc.：石油・ガスの開発・生産動向及びコスト分析- 2012Contact Exploration Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - 2012 Summary Contact Exploration Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential sour …
- 世界の自動車クーラント市場2015The Global Automotive Coolant Industry Report 2015 is a professional and in-depth study on the current state of the Automotive Coolant industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Automotive Coolant market analysis is provided for the international markets including development trends, competiti …
- ガスケット及びシールの世界市場2016-2020About Gasket and Seals Seals and gaskets play a vital role in any assembly process. These components are widely used to fit two mating surfaces to prevent leakage. - Seals A seal is used to control leakage of liquids or gases in the automotive, manufacturing, aerospace, electrical and electronics and petrochemical industries. Seals help in reducing problems associated with pollution due to leakage …
- 重症筋無力症治療薬の世界市場2017-2021：抗コリンエステラーゼ薬、免疫抑制剤、免疫グロブリン静注療法（IVIg）About Myasthenia Gravis Drugs Currently, the myasthenia gravis drugs market stands at a small size due to limited availability of approved therapies for the complete remission of the disease. However, the anticipated approval of novel drugs such as monoclonal antibodies should help market witness strong growth during the forecast period. For instance, Alexion Pharmaceuticals is currently developin …
- OJSC Rosneft Oil Company：石油・ガスの開発・生産動向及びコスト分析– Q1, 2013OJSC Rosneft Oil Company Oil & Gas Exploration and Production Operations and Cost Analysis – Q1, 2013 Summary OJSC Rosneft Oil Company Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential …
- 世界ヘルスケア産業のLBS市場：Global LBS Market in the Healthcare Industry 2014-2018TechNavio's analysts forecast the Global LBS market in the Healthcare industry to grow at a CAGR of 29.36 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing requirement of real-time location-based people tracking in hospitals. The Global LBS market in the Healthcare industry has also been witnessing the increasing use of LBS in hospital g …
- Laryngeal Cancer：グローバル臨床試験レビューH2, 2013Laryngeal Cancer Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Laryngeal Cancer Global Clinical Trials Review, H2, 2013" provides data on the Laryngeal Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Laryngeal Cancer. It includes an overview of the trial numbers and their recruitment statu …
- 世界のデンタル消耗品市場動向（2012-2016）TechNavio’s analysts forecast the Global Dental Consumables market 2012-2016 to grow at a CAGR of 6.10 percent over the period 2012-2016. One of the key factors contributing to this market growth is increase in number of dental procedures. The Global Dental Consumables market has also been witnessing the trend of growing popularity of dental tourism. However, lack of awareness about dental problem …
- 産業用クラッチ及びブレーキの世界市場2017-2021About Industrial Clutches and Brakes Clutches and brakes are widely used in industrial applications for transmitting mechanical power between the driving shaft and driven shaft. An industry chooses clutches, brakes, or a combination of these two based on application. Technavio’s analysts forecast the global industrial clutches and brakes market to grow at a CAGR of 1.65% during the period 2017-202 …
- キャリアスクリーニングの世界市場予測（～2024年）“Increasing emphasis on early disease detection and prevention is expected to drive the growth of the global carrier screening market.” The global carrier screening market size is expected to grow from USD 1.8 billion in 2019 to USD 4.0 billion by 2024, at a CAGR of 17.5% during the forecast period. Growth in the carrier screening market can primarily be attributed to factors such as increasing em …
- スマートグリッド用センサーの世界市場About Smart Grid SensorsSmart grid sensors are compact electrical devices used for detecting and monitoring power system equipment. They track the power line temperatures and weather conditions around the power cables, and are also used to calculate the current carrying capacity of transmission lines. Technavio’s analysts forecast the global Smart Grid Sensors market to grow at a CAGR of 15.28% du …
- プロキシミティ・マーケティングの世界市場予測（～2022年）In the modern world of advanced technologies, proximity marketing is a promising and upcoming medium in the field of information and advertising across sectors. The proximity marketing market was valued at USD 9.01 Billion in 2015 and is expected to reach USD 52.46 Billion by 2022, at a CAGR of 29.8% during the forecast period. Proximity marketing is gaining traction among retailers to send specia …
